Hai Ping Shi
Director Financiero/CFO en QILN HLDG .
Fortuna: 6 M $ al 30/04/2024
Perfil
Hai Ping Shi is currently working as the Chief Financial Officer at Gansu Qilianshan Pharmaceutical Co., Ltd.
since 2018 and at Qilian International Holding Group Ltd.
since 2023.
Prior to her current roles, she obtained an undergraduate degree from Gansu Radio & Television University in 1995.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2023 | 7 131 000 ( 19.95% ) | 6 M $ | 30/04/2024 |
Cargos activos de Hai Ping Shi
| Empresas | Cargo | Inicio |
|---|---|---|
| QILN HLDG | Director Financiero/CFO | 15/06/2020 |
Gansu Qilianshan Pharmaceutical Co., Ltd.
 Gansu Qilianshan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Gansu Qilianshan Pharmaceutical Co., Ltd. is a Chinese company that manufactures drugs. The private company is based in Jiuquan, China. | Director Financiero/CFO | 01/04/2018 |
Formación de Hai Ping Shi.
| Gansu Radio & Television University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| QILN HLDG | Health Technology |
| Empresas privadas | 1 |
|---|---|
Gansu Qilianshan Pharmaceutical Co., Ltd.
Gansu Qilianshan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Gansu Qilianshan Pharmaceutical Co., Ltd. is a Chinese company that manufactures drugs. The private company is based in Jiuquan, China. | Health Technology |
- Bolsa de valores
- Insiders
- Hai Ping Shi
